Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Macular degeneration gains higher UK profile:

This article was originally published in Clinica

Executive Summary

The diagnosis and treatment of age-related macular degeneration (AMD), an area of growing interest, is currently the subject of several research projects funded by the UK Department of Health. Funded through the Medical Research Council, these include studies into the genetic susceptibility to the disease, which has received a £1.5 million ($2.1 million) grant. A clinical trial assessing radiotherapy in the treatment of subfoveal neovascular membranes in AMD is also underway at the Royal Victoria Hospital in Belfast.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT071497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel